Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabipur immunization study for antibodies against European bat lyssavirus
2012-002096-34Phase 2Active
- Sponsor
- Crucell
- Start
- Jul 2012
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Rabies vaccine in rabies and European bat lyssavirus infection (EBLV), sponsored by Crucell. Started Jul 2012; status: active.
02
Drugs
Rabies vaccine
03
Conditions
rabiesEuropean bat lyssavirus infection (EBLV)
Beyond the preview
Go deeper on 2012-002096-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002096-34.